成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Talizumab

Talizumab Struktur
380610-22-0
CAS-Nr.
380610-22-0
Englisch Name:
Talizumab
Synonyma:
Hu-901;Hu 901;Tnx-901;Tnx 901;Talizumab;Research Grade Talizumab;Research Grade Talizumab (DHJ92703);Immunoglobulin G, anti-(human immunoglobulin E fc region) (human-mouse monoclonal hu901 gamma-chain), disulfide with human-mouse monoclonal hu901 kappa-chain, dimer
CBNumber:
CB62128760
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Talizumab Eigenschaften

Sicherheit

Talizumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Treatment to increase the threshold for peanut-induced anaphylaxis from unintended ingestion by those with peanut allergy.

Talizumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Talizumab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing HuaMeiHuLiBiological Chemical 010-56205725
waley188@sohu.com China 12335 58
Shanghai Han-Xiang Chemical Co., Ltd. 15971444841
amber@biochempartner.com China 3061 58
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340
981810490@qq.com China 1566 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062
422450190@qq.com China 10457 58
Biolab Reagents 027-65279366 18108604862
products@biolabreagent.com China 9818 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
customer_service@efebio.com China 11974 58
Wanxin Biotechnology (Jiaxing) Co., LTD 0573-83568680 18057391398
3956524501@qq.com China 1442 58
Atagenix Laboratories 027-87008169 17762441161
info@atagenix.com China 9848 58

380610-22-0()Verwandte Suche:


  • Talizumab
  • Hu 901
  • Hu-901
  • Immunoglobulin G, anti-(human immunoglobulin E fc region) (human-mouse monoclonal hu901 gamma-chain), disulfide with human-mouse monoclonal hu901 kappa-chain, dimer
  • Tnx 901
  • Tnx-901
  • Research Grade Talizumab (DHJ92703)
  • Research Grade Talizumab
  • 380610-22-0
Copyright 2019 ? ChemicalBook. All rights reserved